• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄牙史密斯-勒米-奥皮茨综合征患者的分子研究及DHCR7基因三个新突变的报告

Molecular studies in Portuguese patients with Smith-Lemli-Opitz syndrome and report of three new mutations in DHCR7.

作者信息

Cardoso M L, Balreira A, Martins E, Nunes L, Cabral A, Marques M, Lima M Reis, Marques J S, Medeira A, Cordeiro I, Pedro S, Mota M C, Dionisi-Vici C, Santorelli F M, Jakobs C, Clayton P T, Vilarinho L

机构信息

Instituto de Genética Médica Jacinto de Magalhães, Oporto, Portugal.

出版信息

Mol Genet Metab. 2005 Jul;85(3):228-35. doi: 10.1016/j.ymgme.2005.02.009. Epub 2005 Apr 14.

DOI:10.1016/j.ymgme.2005.02.009
PMID:15979035
Abstract

Smith-Lemli-Opitz syndrome (SLO) is an autosomal recessive disorder characterised by craniofacial dysmorphism, mental retardation, multiple congenital anomalies, and increased levels of 7-dehydrocholesterol (7-DHC) in body tissues and fluids. SLO is caused by mutations in the DHCR7 gene which encodes 7-dehydrocholesterol reductase, the last enzyme of cholesterol biosynthesis pathway. In our investigation, we screened 682 dysmorphic/mentally retarded Portuguese patients for abnormal levels of 7-DHC in blood by UV spectrometry. We identified six unrelated patients with SLO (0.87% of total). Mutational analysis of the DHCR7 gene led to the identification of seven distinct mutations, three of which are new (F174S, H301R, and Q98X). The common IVS8-1G > C and T93M variants together with the H301R accounted for 70% of the all SLO alleles in our population. Our findings contribute to the variegate array of pathological changes in the DHCR7 gene among different European populations.

摘要

史密斯-勒米-奥皮茨综合征(SLO)是一种常染色体隐性疾病,其特征为颅面畸形、智力迟钝、多种先天性异常以及身体组织和体液中7-脱氢胆固醇(7-DHC)水平升高。SLO由DHCR7基因突变引起,该基因编码7-脱氢胆固醇还原酶,这是胆固醇生物合成途径中的最后一种酶。在我们的研究中,我们通过紫外光谱法对682名葡萄牙颅面畸形/智力迟钝患者的血液中7-DHC水平进行了筛查。我们鉴定出6名无亲缘关系的SLO患者(占总数的0.87%)。对DHCR7基因的突变分析导致鉴定出7种不同的突变,其中3种是新的(F174S、H301R和Q98X)。常见的IVS8-1G > C和T93M变异以及H301R在我们的人群中占所有SLO等位基因的70%。我们的研究结果有助于了解不同欧洲人群中DHCR7基因的各种病理变化。

相似文献

1
Molecular studies in Portuguese patients with Smith-Lemli-Opitz syndrome and report of three new mutations in DHCR7.葡萄牙史密斯-勒米-奥皮茨综合征患者的分子研究及DHCR7基因三个新突变的报告
Mol Genet Metab. 2005 Jul;85(3):228-35. doi: 10.1016/j.ymgme.2005.02.009. Epub 2005 Apr 14.
2
Spectrum of DHCR7 mutations in Slovak patients with Smith-Lemli-Opitz syndrome and detection of common mutations by PCR-based assays.斯洛伐克史密斯-勒米-奥皮茨综合征患者中DHCR7突变谱及基于PCR的检测常见突变方法
Gen Physiol Biophys. 2009 Mar;28(1):8-15.
3
Identification of nine novel DHCR7 missense mutations in patients with Smith-Lemli-Opitz syndrome (SLOS).在史密斯-勒米-奥皮茨综合征(SLOS)患者中鉴定出9种新的DHCR7错义突变。
Hum Mutat. 2005 Jul;26(1):59. doi: 10.1002/humu.9346.
4
Maternal apo E genotype is a modifier of the Smith-Lemli-Opitz syndrome.母亲的载脂蛋白E基因型是史密斯-勒米-奥皮茨综合征的一个修饰因子。
J Med Genet. 2004 Aug;41(8):577-84. doi: 10.1136/jmg.2004.018085.
5
Age and origin of major Smith-Lemli-Opitz syndrome (SLOS) mutations in European populations.欧洲人群中主要史密斯-勒米-奥皮茨综合征(SLOS)突变的年龄和起源。
J Med Genet. 2008 Apr;45(4):200-9. doi: 10.1136/jmg.2007.053520. Epub 2007 Oct 26.
6
DHCR7 mutations and genotype-phenotype correlation in 37 Polish patients with Smith-Lemli-Opitz syndrome.37例波兰史密斯-勒米-奥皮茨综合征患者的DHCR7突变及基因型-表型相关性
Clin Genet. 2004 Dec;66(6):517-24. doi: 10.1111/j.1399-0004.2004.00350.x.
7
Mild Smith-Lemli-Opitz syndrome: further delineation of 5 Polish cases and review of the literature.轻度史密斯-勒米-奥皮茨综合征:5例波兰病例的进一步描述及文献综述
Eur J Med Genet. 2008 Mar-Apr;51(2):124-40. doi: 10.1016/j.ejmg.2007.11.004. Epub 2007 Dec 8.
8
Lowered DHCR7 activity measured by ergosterol conversion in multiple cell types in Smith-Lemli-Opitz syndrome.在史密斯-勒米-奥皮茨综合征的多种细胞类型中,通过麦角固醇转化测定的DHCR7活性降低。
Mol Genet Metab. 2004 Sep-Oct;83(1-2):175-83. doi: 10.1016/j.ymgme.2004.07.002.
9
Identification of 14 novel mutations in DHCR7 causing the Smith-Lemli-Opitz syndrome and delineation of the DHCR7 mutational spectra in Spain and Italy.在西班牙和意大利鉴定出导致史密斯-勒米-奥皮茨综合征的DHCR7基因的14个新突变,并描绘DHCR7基因突变谱。
Hum Mutat. 2005 Apr;25(4):412. doi: 10.1002/humu.9328.
10
RSH/Smith-Lemli-Opitz syndrome: a multiple congenital anomaly/mental retardation syndrome due to an inborn error of cholesterol biosynthesis.RSH/史密斯-勒米-奥皮茨综合征:一种由于胆固醇生物合成先天性缺陷导致的多发性先天性异常/智力发育迟缓综合征。
Mol Genet Metab. 2000 Sep-Oct;71(1-2):163-74. doi: 10.1006/mgme.2000.3069.

引用本文的文献

1
Investigation of 7-dehydrocholesterol reductase pathway to elucidate off-target prenatal effects of pharmaceuticals: a systematic review.探究7-脱氢胆固醇还原酶途径以阐明药物的非靶向产前效应:一项系统评价
Pharmacogenomics J. 2016 Oct;16(5):411-29. doi: 10.1038/tpj.2016.48. Epub 2016 Jul 12.
2
The p.Phe174Ser mutation is associated with mild forms of Smith Lemli Opitz Syndrome.p.Phe174Ser突变与轻度形式的史密斯-勒米-奥皮茨综合征相关。
BMC Med Genet. 2016 Mar 11;17:22. doi: 10.1186/s12881-016-0287-1.
3
Recent insights into the Smith-Lemli-Opitz syndrome.
关于史密斯-勒米-奥皮茨综合征的最新见解。
Clin Genet. 2005 Nov;68(5):383-91. doi: 10.1111/j.1399-0004.2005.00515.x.